LOWY 2015* Michelle Ruhle
Children's Cancer Institute, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
A novel anti-cancer agent that sensitizes neuroblastoma cells to chemotherapy and targets cellular metabolism (#115)
2:15 PM
Claudia Flemming
Afternoon Tea/Poster Session
CBL0137, a novel NFkB suppressor and p53 activator, is highly effective in two independent pre-clinical mouse models of neuroblastoma (#136)
2:15 PM
Jayne Murray
Afternoon Tea/Poster Session